Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Allen

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 4, 2003
Brain uptake of thiamine-coated nanoparticlesPaul R Lockman, Moses O Oyewumi, Joanna M Koziara, et al.
Neurochemical Research|June 8, 2006
Nicotine exposure does not alter plasma to brain choline transferPaul R Lockman, Julie Gaasch, Ghia McAfee, et al.
American Journal of Pharmaceutical Education|July 24, 2021
Adaptability, Agency, and Association to Influence Change: The Report of the 2020-21 AACP Argus CommissionCynthia J Boyle, David D Allen, Joseph T DiPiro, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 22, 2005
Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseasesZhengrong Cui, Paul R Lockman, Craig S Atwood, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 2005
Tobacco smoke chemicals attenuate brain-to-blood potassium transport mediated by the Na,K,2Cl-cotransporter during hypoxia-reoxygenationJennifer R Paulson, Karen E Roder, Ghia McAfee, et al.
Pharmaceutical Research|May 20, 2003
In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticlesPaul R Lockman, Joanna Koziara, Karen E Roder, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2010
Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporterGuangrong Zheng, Zhenfa Zhang, Paul R Lockman, et al.
American Journal of Pharmaceutical Education|November 5, 2020
Advancing Our Pharmacy Reformation - Accelerating Education and Practice Transformation: Report of the 2019-2020 Argus CommissionPatricia A Chase Chair, David D Allen, Cynthia J Boyle, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Molecular modeling studies on the active binding site of the blood-brain barrier choline transporterWerner J Geldenhuys, Paul R Lockman, James H McAfee, et al.
Journal of Neuroscience Research|August 31, 2006
Knockdown of amyloid precursor protein normalizes cholinergic function in a cell line derived from the cerebral cortex of a trisomy 16 mouse: An animal model of down syndromePatricia Opazo, Katherine Saud, Michelle de Saint Pierre, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 4, 2003
Brain uptake of thiamine-coated nanoparticlesPaul R Lockman, Moses O Oyewumi, Joanna M Koziara, et al.
Neurochemical Research|June 8, 2006
Nicotine exposure does not alter plasma to brain choline transferPaul R Lockman, Julie Gaasch, Ghia McAfee, et al.
American Journal of Pharmaceutical Education|July 24, 2021
Adaptability, Agency, and Association to Influence Change: The Report of the 2020-21 AACP Argus CommissionCynthia J Boyle, David D Allen, Joseph T DiPiro, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 22, 2005
Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseasesZhengrong Cui, Paul R Lockman, Craig S Atwood, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 22, 2005
Tobacco smoke chemicals attenuate brain-to-blood potassium transport mediated by the Na,K,2Cl-cotransporter during hypoxia-reoxygenationJennifer R Paulson, Karen E Roder, Ghia McAfee, et al.
Pharmaceutical Research|May 20, 2003
In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticlesPaul R Lockman, Joanna Koziara, Karen E Roder, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2010
Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporterGuangrong Zheng, Zhenfa Zhang, Paul R Lockman, et al.
American Journal of Pharmaceutical Education|November 5, 2020
Advancing Our Pharmacy Reformation - Accelerating Education and Practice Transformation: Report of the 2019-2020 Argus CommissionPatricia A Chase Chair, David D Allen, Cynthia J Boyle, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Molecular modeling studies on the active binding site of the blood-brain barrier choline transporterWerner J Geldenhuys, Paul R Lockman, James H McAfee, et al.
Journal of Neuroscience Research|August 31, 2006
Knockdown of amyloid precursor protein normalizes cholinergic function in a cell line derived from the cerebral cortex of a trisomy 16 mouse: An animal model of down syndromePatricia Opazo, Katherine Saud, Michelle de Saint Pierre, et al.
Pageof 6